
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
Zfp36l1 (zinc finger protein 36, C3H type-like 1) encodes an RNA-binding protein that recognizes AU-rich regions in the 3′ untranslated regions of messenger RNAs and promotes mRNA destabilization. It participates in post-transcriptional gene regulation and cellular responses to cAMP and raffinose. ZFP36L1 also contributes to chordate embryonic development and circulatory system development. It is located in the cytoplasm and nucleus and is part of a ribonucleoprotein complex. Its human ortholog is ZFP36L1.
A murine colon adenocarcinoma cell line derived from a BALB/c mouse and induced by N-nitroso-N-methylurethane (NNMU). The parental CT26 line was established from colon tissue, and CT26.WT represents a cloned derivative of this tumor cell line.
Each knockout cell line is validated by STR authentication, sterility testing (bacteria/fungi), and mycoplasma screening. Genotype is confirmed by two rounds of PCR and Sanger sequencing. Only clones that pass all QC criteria are released, ensuring reliable identity and performance for downstream applications.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?